Fibromyalgia (Fibromyalgia Syndrome) – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Fibromyalgia (Fibromyalgia Syndrome) – Drugs In Development, 2024 report and make more profitable business decisions.
Fibromyalgia is a disorder characterized by widespread musculoskeletal pain accompanied by fatigue, sleep, memory, and mood issues. Symptoms include fatigue, depression, headaches, and pain or cramping in the lower abdomen. The predisposing factors include family history, rheumatoid arthritis, or lupus. Treatment includes pain relievers, antidepressants, and anti-seizure drugs.
The Fibromyalgia (Fibromyalgia Syndrome) drugs in development market research report provide comprehensive information on the therapeutics under development for Fibromyalgia (Fibromyalgia Syndrome), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Fibromyalgia (Fibromyalgia Syndrome) and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Fibromyalgia (Fibromyalgia Syndrome) | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 26 molecules, with 25 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Fibromyalgia (Fibromyalgia Syndrome) therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Fibromyalgia (Fibromyalgia Syndrome) pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Fibromyalgia (Fibromyalgia Syndrome) treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Axsome Therapeutics IncBiomind Labs Inc
Cellix Bio Pvt Ltd
Cortene Inc
Engrail Therapeutics Inc
Federal University of Minas Gerais
FSD Pharma Inc
Imbrium Therapeutics LP
Indaptus Therapeutics Inc
Luye Pharma Group Ltd
One World Cannabis Ltd
Scilex Holding Co
Seurat Therapeutics Inc
Shanghai Leado Pharmaceutical Technology Co Ltd
Silo Pharma Inc
Statera Biopharma Inc
Tetra Bio-Pharma Inc
Tonix Pharmaceuticals Holding Corp
Tryp Therapeutics Inc
UCB SA
Virios Therapeutics
Inc
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Fibromyalgia (Fibromyalgia Syndrome) reports